Bio-Techne Corporation (TECH)

NMS – Цена в реальном времени. Валюта: USD

72.25

+0.10 (0.13%)

Рынок открыт: Aug 12, 2026, 1:34 PM EDT

72.20

+0.05 (0.07%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

12.08.2026

Techne (TECH) Q4 Earnings Meet Estimates

Techne (TECH) came out with quarterly earnings of $0.52 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.53 per share a year ago.

12.08.2026

Bio-Techne beats revenue estimates on research, diagnostics demand uptick

Bio-Techne beat Wall Street estimates for fourth-quarter revenue on Wednesday helped by growth in ‌its research and diagnostics businesses.

12.08.2026

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2026. Fourth Quarter FY2026 Highlights Fourth quarter organic revenue increased by 3% (1% reported) to $321.2 million.

12.08.2026

Bio-Techne Declares Dividend

MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026. The quarterly dividend will be payable August 28, 2026, to all common shareholders of record on August 17, 2026.

06.08.2026

JAZZ vs. TECH: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Jazz Pharmaceuticals (JAZZ) and Techne (TECH). But which of these two stocks presents investors with the better value opportunity right now?

Видео

No Data

There is no data to display

Пресс-релизы

12.08.2026

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

12.08.2026

Bio-Techne Corporation (TECH)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях